AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
10.64
-0.68 (-6.01%)
At close: Apr 28, 2026, 4:00 PM EDT
10.11
-0.53 (-4.98%)
After-hours: Apr 28, 2026, 4:20 PM EDT
AgomAb Therapeutics NV Market Cap
AgomAb Therapeutics NV has a market cap or net worth of $519.05 million as of April 28, 2026.
Market Cap
519.05M
Enterprise Value
376.90M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.64
Market Cap Chart
Since the IPO on February 6, 2026, AgomAb Therapeutics NV's market cap has decreased from $779.79M to $519.05M, a decrease of -33.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 551.70M | -29.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 597.88M |
| Shattuck Labs | 596.34M |
| Zevra Therapeutics | 595.29M |
| CorMedix | 595.27M |
| Kyverna Therapeutics | 581.70M |
| Ocugen | 578.86M |
| Prothena Corporation | 576.55M |
| Altimmune | 561.24M |